The overall structure of the mouse TGI model was kept the same, but the mouse system parameters such as initial tumor size, tumor growth rate, and receptor expression were replaced with clinically relevant parameters for HER2+ MBC. This evidence concerns the gene ERBB2 and neoplasm.